scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1112739248 |
P356 | DOI | 10.1186/S13287-019-1184-2 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s13287-019-1184-2 |
P932 | PMC publication ID | 6417089 |
P698 | PubMed publication ID | 30867056 |
P50 | author | Yujun Shi | Q89544524 |
P2093 | author name string | Bo Zhang | |
Prue Talbot | |||
Qing Xu | |||
Yanrong Lu | |||
Gang Guo | |||
Hong Bu | |||
Yongjie Zhu | |||
Junjun She | |||
Jiayu Liao | |||
Yongjie Zhou | |||
Xiang Zhuang | |||
Yuanmin Li | |||
Zhenru Wu | |||
P2860 | cites work | Mesenchymal stem cells and immunomodulation: current status and future prospects | Q26770191 |
Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis | Q26828535 | ||
Acute liver failure: redefining the syndromes | Q28249118 | ||
Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 | Q29622852 | ||
Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord | Q30160386 | ||
Clinical features and outcome of patients with amatoxin-containing mushroom poisoning | Q33395273 | ||
Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly | Q33746687 | ||
Acute-on-Chronic Liver Failure: Definition, Diagnosis, and Clinical Characteristics. | Q51525651 | ||
Impaired immune and acute-phase responses in interleukin-6-deficient mice. | Q52514391 | ||
Acute Liver Failure | Q56069625 | ||
Mechanism of action of amanitins | Q67711198 | ||
The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure | Q82565554 | ||
Circulating monocytes accelerate acute liver failure by IL-6 secretion in monkey | Q89544526 | ||
Management of acute-on-chronic liver failure: an algorithmic approach | Q90994642 | ||
Interleukin 6 and liver regeneration | Q33969763 | ||
Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans | Q34159110 | ||
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies | Q35200156 | ||
Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection | Q35358973 | ||
A Macaca mulatta model of fulminant hepatic failure | Q35725840 | ||
Resveratrol stimulates AMP kinase activity in neurons | Q35758555 | ||
Legalon® SIL: the antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning | Q36150243 | ||
Soluble CD163 from activated macrophages predicts mortality in acute liver failure | Q36333669 | ||
Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients | Q36861401 | ||
Concise review: mesenchymal stem cells and translational medicine: emerging issues. | Q37056276 | ||
The importance of immune dysfunction in determining outcome in acute liver failure | Q37272915 | ||
Granzyme K synergistically potentiates LPS-induced cytokine responses in human monocytes | Q37725297 | ||
Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications | Q37988754 | ||
The evolving story of macrophages in acute liver failure | Q38028255 | ||
Mesenchymal stromal cells: sensors and switchers of inflammation | Q38149359 | ||
Modulation of monocyte/macrophage function: a therapeutic strategy in the treatment of acute liver failure. | Q38202361 | ||
Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy | Q38332930 | ||
IL-6 as a keystone cytokine in health and disease | Q38433045 | ||
Stem Cell Therapies in Clinical Trials: Progress and Challenges | Q38542432 | ||
Clinical Trials With Mesenchymal Stem Cells: An Update. | Q38596084 | ||
Acute-on-chronic liver failure: terminology, mechanisms and management | Q38720387 | ||
The systemic inflammatory response syndrome in acute liver failure | Q45243727 | ||
Human liver stem cells improve liver injury in a model of fulminant liver failure. | Q47345053 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | monocyte | Q107244 |
liver failure | Q970208 | ||
mesenchymal stem cell | Q1922379 | ||
Quadrumana | Q4514984 | ||
interleukin-6 | Q24724988 | ||
human umbilical cord mesenchymal stem cell | Q107296600 | ||
P304 | page(s) | 84 | |
P577 | publication date | 2019-03-12 | |
P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
P1476 | title | Peripheral infusion of human umbilical cord mesenchymal stem cells rescues acute liver failure lethality in monkeys | |
P478 | volume | 10 |
Q98291530 | Clinical application of stem cell in patients with end-stage liver disease: progress and challenges |
Q97524974 | Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis |
Q92886174 | Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p |
Q99556559 | Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance via PTEN-mediated crosstalk between the PI3K/Akt and Erk/MAPKs signaling pathways in the skeletal muscles of db/db mice |
Search more.